...
【24h】

Drug-induced liver disease

机译:药物性肝病

获取原文
获取原文并翻译 | 示例
           

摘要

The year 2002 saw a warning from the US Food and Drug Administration not to use the diet agent, Lipokinetix, and brought to light a few new agents as potential hepatotoxins. Numerous other reports confirmed the hepatotoxicity of several previously described agents. Refinements in causality assessment remain an important aspect in defining drug-induced liver disease and proposed new upper limits of normal for alanine aminotransferase that are lower than most laboratories currently report may require rethinking our definition of "normal liver function tests." Chronic viral hepatitis B and C remain important risk factors for antiretroviral-induced liver injury in patients co-infected with the human immunodeficiency virus and in patients receiving antituberculosis therapy. Acetaminophen retains its status as the most common cause of acute drug-induced liver failure in the United States and in many other countries. Several papers addressed the issue of accidental versus intentional overdoses, the role of alcohol consumption as a risk factor, and newer aspects of treating and preventing acetaminophen injury to the liver. Finally, the use of potentially hepatotoxic medications in patients with underlying liver disease continues to be a controversial topic and a rational approach to the use of such drugs in this setting is provided.
机译:2002年,美国食品和药物管理局警告不要使用减肥药Lipokinetix,并发现了一些新的药物作为潜在的肝毒素。许多其他报告证实了几种先前描述的药物的肝毒性。因果关系评估的细化仍然是定义药物诱发的肝病的重要方面,并且提议的丙氨酸转氨酶正常值的新上限低于目前大多数实验室的报告,可能需要重新考虑我们对“正常肝功能测试”的定义。乙型和丙型慢性病毒性肝炎仍然是感染人类免疫缺陷病毒的患者和接受抗结核治疗的患者抗逆转录病毒引起的肝损伤的重要危险因素。在美国和许多其他国家/地区,对乙酰氨基酚仍是急性药物性肝衰竭的最常见原因。几篇论文讨论了意外和故意过量使用,饮酒作为危险因素的作用以及治疗和预防对乙酰氨基酚对肝脏的损伤等新问题。最后,在潜在的肝病患者中使用潜在的肝毒性药物仍然是一个有争议的话题,并且提供了在这种情况下使用此类药物的合理方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号